COLPAL NSE filing

Colgate Palmolive India Q4 FY26: Net Sales Grow 9%, Domestic Growth at 9.2%

The RealCase readMedium impact Positive

Colgate-Palmolive (India) Limited reported Q4 FY26 net sales growth of 9% to ₹1,583 crore, with domestic growth at 9.2%. Gross margins were 69.6% and EBITDA margins over 32%. NPAT stood at ₹353 crore. The company highlighted strong brand health and strategic focus on premiumization and innovation across its product portfolio.

Why it matters

The announcement details quarterly results and strategic progress, which are important for investors but do not represent a major corporate action or a significant deviation from expectations.

The market read

The company reported positive sales growth, strong margins, and highlighted strategic initiatives and brand strength, indicating a positive outlook.

Colgate-Palmolive (India) Limited announced its financial results for the fourth quarter and full financial year ended March 31, 2026. For the quarter, the company reported a top-line of ₹1,583 crore, marking a 9% year-on-year growth. Domestic growth was slightly ahead at 9.2%, with broad-based growth across the portfolio including Core and Premium segments, Toothpaste, Toothbrush, and Personal Care.

Gross margins remained strong at 69.6%, and EBITDA margins exceeded 32%. Brand investments saw a significant step-up of 10% year-on-year, amounting to just under ₹200 crore. Net Profit After Tax (NPAT) stood at ₹353 crore, with growth in line with the overall top-line growth, excluding one-off items.

The full-year performance was described as flat, impacted by challenging quarters in the previous calendar year. However, the second half of the financial year showed growth of over 5% compared to the first half. The company highlighted the continued strength of the Colgate brand, with stable or increasing brand health metrics across Top-Of-Mind Awareness, Dentists Recommend, and Oral Care Expertise.

Strategic initiatives include driving consumption through programs like "Bright Smiles, Bright Future" which has reached over a crore children in 2025, and expanding government partnerships for oral health education. The company is also focusing on premiumization with brands like Colgate Total, Colgate Visible White Purple, and its therapeutics portfolio under PerioGuard, which is doubling year-on-year.

In the Toothbrush category, Colgate offers products across the value, mid-tier, and premium segments, with new launches including brushes for Colgate Total, PerioGuard, and Visible White. The Palmolive brand is focusing on Hand Wash and Body Wash, with innovations in the "Moments Range" and a digital-first approach for Body Wash.

The company emphasized its commitment to product and packaging superiority, underpinned by strong science and innovation, including future launches like a "Harry Potter" range and new "Max Fresh Sensorials". Execution remains a strong point, with a reach of 1.7 million outlets and an enhanced "Smile Store Program" leveraging AI for assortment management. Digital shelves and e-commerce are also contributing positively to growth and premiumization.

Filing to action

What to do with a filing like this

Colgate Palmolive (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Colgate Palmolive (India) Limited. Read the original for the full detail.

View original filing